Jinyang to patent an anti-cancer therapy in America.

Published: 2006-01-31 06:59:00

Updated: 2006-01-31 06:59:00

Jinyang pharmaceutical company, a Kosdaq listed company of Korea, announced that the company took a patent registration of an anti-leukemia drug in the United States under the number of Pat. No. 6989143.

The company said that the patent titled "Removing method of plasma ascorbate" characteri...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK